Amphastar Pharma (AMPH) Swings to Q3 Loss

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of ($0.07), versus $0.05 reported last year. Revenue for the quarter came in at $59.71 million, versus $59.32 million reported last year.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Freeport-McMoRan shares surge as copper hits record $14,694/ton
• Braze stock tumbles 10% on weak third quarter EPS guidance